Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Recurrent Extracranial Carotid Artery Vasospasms. Report of 2 Cases
Stroke 37:2170-2173, Janzarik,W.G.,et al, 2006
Stroke in Pregnancy
Neurol Clin 22:821-840, Turan,T.N. &Stern,B.J., 2004
Calcium Antagonists for Ischemic Stroke
Stroke 32:570-576, Horn,J. &Limburg,M., 2001
A Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke
Stroke 25:1348-1353, Kaste,M.,et al, 1994
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
Clinical Trial of Nimodipine in Acute Ischemic Stroke
The American Nimodipine Study Group, Stroke 23:3-81992., , 1992
Cortical Blindness after Nifedipine Treatment
BMJ 305:693, Morton,C.&Hickey-Dwyer,M., 1992
Early Treatment of Ischemic Stroke with a Calcium Antagonist
Stroke 22:437-441, Rosenbaum,D.,et al, 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Calcium Antagonists:Stroke Therapy Coming of Age
Stroke 21:494-501, Wong,M.C.W.&Haley,E.C., 1990
Effect of Nimodipine on Cerebral Infarction & Outcome after Subarachnoid Haemorrhage:British Aneurysm Nimodipine Trial
BMJ 298:636-642, Pickard,J.D.,et al, 1989
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
NEJM 318:203-207, Gelmers,H.J.,et al, 1988
Effect of Calcium Antagonists on the Cerebral Circulation
(Supplement) Am J Cardiol 59:173B-176B987., Gelmers,H.J., 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
A 56-Year-Old Man with Unusual Presentation of Subacute Encephalopathy and Seizure
Neurol 98:e95-e102, Wang, T.,et al, 2022
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009
Left Insular Stroke is Associated with Adverse Cardiac Outcome
Neurol 66:477-483, Laowattana,S.,et al, 2006
Stroke in Williams Syndrome
Stroke 27:143-146, Wollack,J.B.,et al, 1996
Trial of Secondary Prevention with Atenolol after Transient Ischemic Attack or Nondisabl Ischemic Stroke
Dutch TIA Study Group, Stroke 24:543-5481993., , 1993
Cardioembolic Stroke in Primary Oxalosis with Cardiac Involvement
DiPasquale. G. , et al, Stroke 20:1403-14069., , 1989
Low Dose B Blockade in Acute Stroke ("Best"Trial) :An Evaluation
BMJ 296:737-741, Barer,D.H.,et al, 1988
Hypercalcaemia Associated with Cerebral Vasospasm Causing Infarction
JNNP 43:464-467, Walker,G.L.,et al, 1980
Neurologic Manifestations in Sarcoidosis
Ann Int Med 87:336, Delaney,P., 1977